1.6(top 50%)
impact factor
887(top 20%)
papers
4.1K(top 20%)
citations
22(top 20%)
h-index
1.6(top 50%)
extended IF
1.1K
all documents
4.7K
doc citations
33(top 50%)
g-index

Top Articles

#TitleJournalYearCitations
1Detection of microplastics in human colectomy specimensJGH Open2021200
2Epidemiology of non‐alcoholic fatty liver disease‐related hepatocellular carcinoma and its implicationsJGH Open201847
3Probiotics for Parkinson's disease: Current evidence and future directionsJGH Open202141
4Non‐alcoholic fatty pancreas disease as a risk factor for pancreatic cancer based on endoscopic ultrasound examination among pancreatic cancer patients: A single‐center experienceJGH Open201837
5Fecal calprotectin correlates with active colonic inflammatory bowel disease but not with small intestinal Crohn's disease activityJGH Open201836
6Precision treatment in colorectal cancer: Now and the futureJGH Open201936
7Early response and safety of lenvatinib for patients with advanced hepatocellular carcinoma in a real‐world settingJGH Open202036
8Prevalence and risk factors of non‐alcoholic fatty liver disease in BangladeshJGH Open201835
9The effect of vitamin D deficiency on eradication rates of Helicobacter pylori infectionJGH Open201834
10Anemia in celiac disease is multifactorial in etiology: A prospective study from IndiaJGH Open201834
11Systematic review with meta‐analysis: Safety and efficacy of local injections of mesenchymal stem cells in perianal fistulasJGH Open201934
12Non‐alcoholic fatty liver disease in patients with autoimmune hepatitisJGH Open201833
13COVID‐19 and its effects on the digestive system and endoscopy practiceJGH Open202032
14Gut microbiota dysbiosis in functional gastrointestinal disorders: Underpinning the symptoms and pathophysiologyJGH Open202132
15A review of vedolizumab and ustekinumab for the treatment of inflammatory bowel diseasesJGH Open201830
16Thyroid‐stimulating hormone is an independent risk factor of non‐alcoholic fatty liver diseaseJGH Open202030
17Thoracic complications of pancreatitisJGH Open201929
18High prevalence of non‐alcoholic fatty liver disease among healthy male blood donors of urban IndiaJGH Open201929
19Impact of dietary beliefs and practices on patients with inflammatory bowel disease: An observational study from IndiaJGH Open201728
20Gastrointestinal ultrasound in inflammatory bowel disease care: Patient perceptions and impact on disease‐related knowledgeJGH Open202028
21Esophageal tuberculosis: Uncommon of commonJGH Open201827
22Gastrointestinal complications in acute and chronic pancreatitisJGH Open201927
23Psychological distress is highly prevalent in inflammatory bowel disease: A survey of psychological needs and attitudesJGH Open202027
24Assessment of risk factors, and racial and ethnic differences in hepatocellular carcinomaJGH Open202025
25Vitamin D supplementation in patients with nonalcoholic fatty liver disease: A randomized controlled trialJGH Open201724
26Malnutrition and quality of life among adult inflammatory bowel disease patientsJGH Open202023
27Complications of cold versus hot snare polypectomy of 10–20 mm polyps: A retrospective cohort studyJGH Open202022
28Hepatic steatosis as an independent risk factor for severe disease in patients with COVID‐19: A computed tomography studyJGH Open202022
29The prevalence of gastrointestinal symptoms among patients with COVID‐19 and the effect on the severity of the diseaseJGH Open202022
30Discordant pathological diagnosis of non‐alcoholic fatty liver disease: A prospective multicenter studyJGH Open202022
31Idiopathic myointimal hyperplasia of the mesenteric veins: Case report and review of the literatureJGH Open202022
32Effect of 48‐week pemafibrate on non‐alcoholic fatty liver disease with hypertriglyceridemia, as evaluated by the FibroScan‐aspartate aminotransferase scoreJGH Open202121
33Symptomatic severe hypophosphatemia after intravenous ferric carboxymaltoseJGH Open201920
34Conscious sedation using propofol versus midazolam in cirrhotic patients during upper GI endoscopy: A comparative studyJGH Open201920
35Exclusive enteral nutrition: An optimal care pathway for use in adult patients with active Crohn's diseaseJGH Open202020
36Epidemiology of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in Japan: A focused literature reviewJGH Open202020
37Gastrointestinal and hepatic manifestations of COVID ‐19: A systematic review and meta‐analysisJGH Open202120
38Nodular gastritis in association with gastric cancer development before and after Helicobacter pylori eradicationJGH Open201819
39Early experience with a low FODMAP diet in Asian patients with irritable bowel syndromeJGH Open201819
40Optimal cut‐off value of fecal calprotectin for the evaluation of ulcerative colitis: An unsolved issue?JGH Open201819
41Quality of life in celiac disease and the effect of gluten‐free dietJGH Open201819
42Noninvasive estimation of intravascular volume status in cirrhosis by dynamic size and collapsibility indices of the inferior vena cava using bedside echocardiographyJGH Open201919
43Abdominal tuberculosis in children: A real‐world experience of 218 cases from an endemic regionJGH Open202019
44Roles of healthcare professionals in the management of chronic gastrointestinal diseases with a focus on primary care: A systematic reviewJGH Open202019
45Asian Pacific Association of Gastroenterology (APAGE) Inflammatory Bowel Disease (IBD) Working Party guidelines on IBD management during the COVID‐19 pandemicJGH Open202019
46Prevalence and impact of Clostridioides difficile infection among hospitalized patients with coranavirus disease 2019JGH Open202119
47Risk of small intestinal bacterial overgrowth in patients receiving proton pump inhibitors versus proton pump inhibitors plus prokineticsJGH Open201818
48Fecal microbiota transplantation: Current status and challenges in ChinaJGH Open201818
49Arterial pseudoaneurysms in acute and chronic pancreatitis: Clinical profile and outcomeJGH Open201918
50Effect of aspirin use on gastric cancer incidence and survival: A systematic review and meta‐analysisJGH Open202018